Thank you Decoding Bio for covering our launch and reviewing our platform on binder design tasks! The authors concluded: 'Latent Lab’s new platform speaks for itself.' Read the full review article here: tinyurl.com/latent-X-decod…

In this week's #RadicalReads, Simon Kohl, Founder and CEO of Latent Labs, explores how the recently launched Latent-X model is making biology programmable by enabling scientists to design novel proteins with atomic precision directly in their browser: radical.vc/making-biology…

Latent-X has been available for a little over two weeks, and we couldn't be more excited about the science that is already being done with it on our platform. Our CEO Simon Kohl joined Bloomberg News Daybreak Europe this morning to talk about why we're building it, and the impact

Really cool to see Nanome review Latent-X in their VR environment! 💻🧬 They pick an unseen target, and find the Latent Labs platform generates diverse binders with highly specific biochemical interactions! 💯 Watch their discussion of the designs here:

We're working with NVIDIA to accelerate computational drug discovery. See how they are working with us and the broader UK AI ecosystem in the press release below, issued as part of the UK state visit. 🇺🇸🇬🇧

Our very own Sebastian Schmon and Simon Mathis will present at In Silico, London, on 1 October. We'll be speaking about Latent-X, our Atom-level Frontier Model for De Novo Protein Binder Design. Also featuring Amy Lu and Dominik Dekleva, we're looking forward to it! Register for In

Proud to share that our founder Simon Kohl was named in the Observer's 2025 A.I. Power Index. Simon Kohl's recognition reflects both his groundbreaking contributions and enduring influence in AI's transformation of biology. See the full roster of A.I. leaders: